BREEMAX-L RESPULES
MRP: 900
Packaging: 4x5x2ml
Pack Type: respules
Composition:
Budesonide 0.5 mg + Levosalbutamol 1.25 mg
Indication:
ASTHMA and COPD
Description:
Budesonide 0.5 mg + Levosalbutamol 1.25 mg is a combination nebulizer respule designed for dual-action management of bronchial asthma, wheezing, and chronic obstructive pulmonary disease (COPD).
Budesonide is a corticosteroid that reduces inflammation, swelling, and mucus production in the airways.
Levosalbutamol is a selective β2-adrenergic receptor agonist that relaxes bronchial muscles, providing quick relief from acute bronchospasm.
This combination offers both immediate and long-term respiratory support, ideal for moderate to severe cases and especially effective in pediatric and elderly populations.
Tags:
- Fast relief from bronchospasm (Levosalbutamol)
- Long-term airway inflammation control (Budesonide)
- Effective in both acute and maintenance therapy
- Suitable for pediatric, adult, and elderly use
- Helps reduce hospitalizations from asthma/COPD exacerbations
Usage Information
Dosage
Usual adult dose: 1 respule (2.5 ml) via nebulizer, once or twice daily Children: As prescribed by a pediatrician Do not exceed recommended frequency Discard any unused solution after opening Rinse mouth post-use to prevent thrush
Side Effects
Hoarseness or sore throat Oral thrush (fungal infection) Shakiness, rapid heartbeat (from Levosalbutamol) Headache, dizziness Rare: paradoxical bronchospasm
Contraindications
Hypersensitivity to Budesonide, Levosalbutamol, or components Use caution in patients with heart disease, diabetes, or thyroid dysfunction Do not use during acute status asthmaticus unmonitored Not to be used as sole therapy for acute asthma attacks
Availability
Budesonide Levosalbutamol respules Budesonide 0.5 mg nebulizer Levosalbutamol 1.25 mg for asthma asthma COPD nebulizer solution pediatric nebulizer medicine dual action asthma treatment steroid + bronchodilator respule nebulizer solution for wheezing